Source: International Congress 2018 – Prematurity and lung disease
Disease area: Paediatric lung diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
R. Viscardi (Baltimore, MD, United States of America), M. Terrin (Baltimore, MD, United States of America), L. Magder (Baltimore, MD, United States of America), S. Dulkerian (Baltimore, MD, United States of America), N. Davis (Baltimore, MD, United States of America), K. Waites (Birmingham, AL, United States of America), N. Ambalavanan (Birmingham, AL, United States of America), P. Donohue (Baltimore, MD, United States of America), D. Kaufman (Charlottesville, VA, United States of America), D. Tuttle (Newark,DE, United States of America), J. Weitkamp (Nashville, TN, United States of America). Azithromycin (AZM) reduces death or severe respiratory morbidity at 12 month adjusted age (AA) in Ureaplasma-positive intubated preterms.. 301

Member's Comments

No comment yet.

Related content which might interest you: A delay in reaching time to clinical stability (tcs) for hospitalized patients with community-acquired pneumonia (CAP) is associated with failure within 30 days after hospital discharge Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Risk factors for lower respiratory illnesses (LRI) in infants < 32 wks gestational age (GA): Do they differ by type of illness? Source: Annual Congress 2011 - Paediatric epidemiology: predicting outcomes of wheeze, antenatal growth, early life exposures and outcome of premature birth Year: 2011 Evaluating the risk of lower respiratory tract infection (LRTI) hospitalizations due to respiratory distress syndrome (RDS) in late preterm Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011 Infant bronchiolitis increases the risk of reduced lung function at age 10-13 years Source: International Congress 2018 – Paediatric respiratory infections: translational and clinical perspectives Year: 2018 Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 641s Year: 2005 Severe community acquired pneumonia (CAP) in ventilated elderly: a 12 yr experience Source: Eur Respir J 2002; 20: Suppl. 38, 475s Year: 2002 Lymphocyte-to-Monocyte ratio (LMR) and Platelet-to-lymphocyte (PLR) ratio levels as a predictors of lung failure in severe Covid-19 pneumonia patients (pts) Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 Arterial pH and PaCO2 (at presentation or pre NIV) are poor predictors of death or length of stay (LOS) in patients receiving non invasive ventilation (NIV) for acute type 2 respiratory failure (T2RF) Source: International Congress 2014 – Improving noninvasive ventilation efficacy Year: 2014 Neonatal antibiotic treatment increases the risk of asthma at age 12 years Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology Year: 2017 Effect of screening for undiagnosed COPD on respiratory hospitalisation and mortality; 4 year follow up of the TargetCOPD trial Source: International Congress 2019 – Management of airway diseases in primary care Year: 2019 Associations between bronchiolitis and respiratory outcomes at 18 years in the PIAF birth cohort Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions Year: 2011 Outcomes in females hospitalised with community-acquired pneumonia are worse than in males Source: Eur Respir J 2013; 41: 1135-1140 Year: 2013 Severe community-acquired pneumonia (S-CAP) in patients aged ≤65 years-old without comorbidities (NOCOM) Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Duration of mechanical ventilation influences lung volume in preterm infants at 15-18 months corrected age Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology Year: 2008 Long-term follow-up of the ISOLDE participants: causes of death after 13 years of the trial completion Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007 Early lower airway infection: risk factors for asthma at age of 14-16 years Source: Eur Respir J 2004; 24: Suppl. 48, 717s Year: 2004 Community acquired pneumonia (CAP) 30 days mortality and biomarkers Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Risk factors for mechanical ventilation (MV) in Brazilian infants with acute lower respiratory infections (LRI) Source: Eur Respir J 2005; 26: Suppl. 49, 627s Year: 2005 Macrolide therapy is associated with lower 30-day mortality in patients with non-pneumonia and pneumonia severe sepsis Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 The most frequent bacterial causes of pneumonia in children over 3 yrs of age - some characteristics Source: Eur Respir J 2002; 20: Suppl. 38, 191s Year: 2002